癫痫患儿镇静苏醒时间延长的危险因素分析

曹一凡; 丁梦微; 熊玲; 徐颖

doi:10.16016/j.2097-0927.202405042

您当前的位置：

首页 >

文章列表页 >

癫痫患儿镇静苏醒时间延长的危险因素分析

临床医学 | 更新时间：2026-01-09

- 癫痫患儿镇静苏醒时间延长的危险因素分析
- Risk factors for prolonged sedation recovery time in children with epilepsy
- 陆军军医大学学报 2024年46卷第14期页码：1653-1657
- 作者机构：
  
  1.400014 重庆，重庆医科大学附属儿童医院，国家儿童健康与疾病临床医学研究中心，儿童发育疾病研究教育部重点实验室，儿童神经发育与认知障碍重庆市重点实验室：麻醉科
  2.400014 重庆，重庆医科大学附属儿童医院，国家儿童健康与疾病临床医学研究中心，儿童发育疾病研究教育部重点实验室，儿童神经发育与认知障碍重庆市重点实验室：儿童医疗健康大数据中心
- 作者简介：
  
  [徐颖，E-mail：xuyingxy3066@126.comXU Ying, E-mail: xuyingxy3066@126.com
- 基金信息：
  
  重庆市科卫联合医学科研项目重大项目(2023DBXM003);重庆市科技局技术创新与应用发展(面上项目)(CSTB2022TIAD-GPX0007)
- DOI：10.16016/j.2097-0927.202405042
  中图分类号： R614.2;R726.1;R742.1
- 收稿：2024-05-11，
  
  修回：2024-06-19，
  
  纸质出版：2024-07-30
- 稿件说明：
移动端阅览
曹一凡, 丁梦微, 熊玲, 等. 癫痫患儿镇静苏醒时间延长的危险因素分析[J]. 陆军军医大学学报, 2024,46(14):1653-1657.

Yifan CAO, Mengwei DING, Ling XIONG, et al. Risk factors for prolonged sedation recovery time in children with epilepsy[J]. Journal of Army Medical University, 2024, 46(14): 1653-1657.
曹一凡, 丁梦微, 熊玲, 等. 癫痫患儿镇静苏醒时间延长的危险因素分析[J]. 陆军军医大学学报, 2024,46(14):1653-1657. DOI： 10.16016/j.2097-0927.202405042.

Yifan CAO, Mengwei DING, Ling XIONG, et al. Risk factors for prolonged sedation recovery time in children with epilepsy[J]. Journal of Army Medical University, 2024, 46(14): 1653-1657. DOI： 10.16016/j.2097-0927.202405042.

摘要

目的

探讨癫痫患儿镇静苏醒时间延长的危险因素。

方法

采用病例-对照研究设计方案，筛选2019年11月至2022年12月在重庆医科大学附属儿童医院接受右美托咪啶联合水合氯醛镇静下行脑电图(electroencephalography

EEG)检查的癫痫患儿，收集患儿的基本信息、镇静资料、用药资料。将超过第75百分位的苏醒时间定义苏醒时间延长，故分为镇静苏醒时间≤1 h组和＞1 h组，采用单因素分析和多因素Logistic回归分析，分析右美托咪啶联合水合氯醛镇静下行脑电图检查的癫痫患儿苏醒时间延长的危险因素。

结果

共纳入1 346例患儿，其中男性805例，女性541例，中位年龄6.03(4.42

8.56)岁。其中苏醒≤1 h组有986例，苏醒＞1 h组有360例。单因素分析显示苏醒≤1 h组与苏醒＞1 h组在年龄＜1岁(0.8%

2.2%

=0.046)、镇静次数≥3次(35.8%

42.2%，

=0.031)、多种抗癫痫药(antiepileptic drugs，AEDs)治疗(25.5%

36.9%，

＜0.001)等指标上差异具有统计学意义。多因素Logistic回归分析显示，年龄＜1岁(

=2.943，95%

：1.063~8.142

=0.034)

、镇静次数≥3次(

=1.287，95%

: 1.003~1.649

=0.047)和多种AEDs治疗(

=1.718，95%

: 1.325~2.223

＜0.001)是苏醒时间延长的危险因素。

结论

年龄＜1岁、镇静次数≥3次、接受多种AEDs治疗是癫痫患儿镇静苏醒时间延长的危险因素。

Abstract

Objective

To analyze the risk factors for prolonged sedation recovery time in epileptic children.

Methods

A cross-sectional trial was conducted on the epileptic children who underwent electroencephalography (EEG) with oral administration of chloral hydrate and nasal dexmedetomidine for sedation in our hospital from November 2019 to December 2022. Their general information and sedation and medication data were collected. Prolonged sedation recovery time was defined as beyond the 75th percentile of awaking time

and then the children were divided into recovery time ≤1 h group and >1 h group. Univariate and multivariable logistic regression analyses were used to identify the risk factors for recovery time in these children.

Results

A total of 1 346 children were enrolled

including 805 males and 541 females

with a median age of 6.03 (4.42

8.56) years. There were 986 children assigned into recovery time ≤1 h group and 360 ones into recovery time

1 h group. Univariate analysis showed that significant differences were observed in the proportions of age

1 year (0.8%

2.2%

=0.046)

sedation more than 3 times (35.8%

42.2%

=0.031)

and treated with multiple antiepileptic drugs (AEDs) (25.5%

36.9%

0.001) between the 2 groups. Multivariable logistic regression analysis indicated that age

1 year (

=2.943

95%

: 1.063~8.142

=0.034)

sedation times ≥3 (

=1.287

95%

: 1.003~1.649

=0.047) and multiple use of AEDs (

=1.718

95%

: 1.325~2.223

0.001) were risk factors for prolonged recovery time.

Conclusion

Age < 1 year

sedation times ≥3 and multiple use of AEDs are risk factors for prolonged sedation recovery time in epileptic children undergoing EEG after oral chloral hydrate and nasal dexmedetomidine.

关键词

Keywords

references

MASON K P, O'MAHONY E, ZURAKOWSKI D, et al . Effects of dexmedetomidine sedation on the EEG in children[J ] . Paediatr Anaesth, 2009, 19(12): 1175-1183. DOI: 10.1111/j.1460-9592.2009.03160.x.

FERNANDES M L, OLIVEIRA W M, SANTOS M D O C, et al . Sedation for electroencephalography with dexmedetomidine or chloral hydrate: a comparative stu dy on the qualitative and quantitative electroencephalogram pattern[J ] . J Neurosurg Anesthesiol, 2015, 27(1): 21-25. DOI: 10.1097/ANA.0000000000000077.

FALLAH R, ALAEI A, AKHAVAN KARBASI S, et al . Chloral hydrate, chloral hydrate: promethazine and chloral hydrate-hydroxyzine efficacy in electroencephalography sedation[J ] . Indian J Pediatr, 2014, 81(6): 541-546. DOI: 10.1007/s12098-013-1298-y.

KRAUSS B, GREEN S M. Procedural sedation and analgesia inchildren[J]. Lancet, 2006, 367(9512): 766-780. DOI: 10.1016/S0140-6736(06)68230-5.

BHATT M, KENNEDY R M, OSMOND M H, et al . Consensus-based recommendations for standardizing terminology and reporting adverse events for emergency department procedural sedation and analgesia in children[J ] . Ann Emerg Med, 2009, 53(4): 426-435. e4. DOI: 10.1016/j.annemergmed.2008.09.030.

KILBAUGH T J, FRIESS S H, RAGHUPATHI R, et al . Sedation and analgesia in children with developmental disabilities and neurologic disorders[J ] . Int J Pediatr, 2010, 2010: 189142. DOI: 10.1155/2010/189142.

PERUCCA E, BRODIE M J, KWAN P, et al . 30 years of second-generation antiseizure medications: impact and future perspectives[J ] . Lancet Neurol, 2020, 19(6): 544-556. DOI: 10.1016/S1474-4422(20)30035-1.

刘晓燕. 小儿难治性癫痫的研究进展[J]. 第三军医大学学报, 2012, 34(22): 2240-2243. DOI: 10.16016/j.1000-5404.2012.22.016.

LIU X Y. Progress in diagnosis and treatment for pediatric intractableepilepsy[J]. J Third Mil Med Univ, 2012, 34(22): 2240-2243. DOI: 10.16016/j.1000-5404.2012.22.016.

中国抗癫痫协会. 临床诊疗指南-癫痫病分册: 2023修订版[M]. 北京: 人民卫生出版社, 2023: 40-48.

China Association Against Epilepsy. Guidelines for clinical diagnosis and treatment-fascicle for epilepsy(revision 2023)[M]. Beijing: People's Health Publishing House, 2023: 40-48.

LUKAWSKI K, CZUCZWAR S J. Understanding mechanisms of drug resistance in epilepsy and strategies for overcomingit[J]. Expert Opin Drug Metab Toxicol, 2021, 17(9): 1075-1090. DOI: 10.1080/17425255.2021.1959912.

中华医学会神经病学分会, 中华医学会神经病学分会脑电图与癫痫学组. 抗癫痫发作药物联合使用中国专家共识[J]. 中华神经科杂志, 2024, 57(2): 108-117. DOI: 10.3760/cma.j.cn113694-20230809-00039.

Neurology Society of Chinese Medical Association, Electroencephalography and Epilepsy Neurology of Chinese Medical Association. Chinese consensus for the antiseizure medications polytherapy[J]. Chin J Neurol, 2024, 57(2): 108-117. DOI: 10.3760/cma.j.cn113694-20230809-00039.

NAMAZI S, BORHANI-HAGHIGHI A, KARIMZADEH I. Adverse reactions to antiepileptic drugs in epileptic outpatients: a cross-sectional study in Iran[J]. Clin Neuropharmacol, 2011, 34(2): 79-83. DOI: 10.1097/WNF.0b013e318210ece0.

JOSHI R, TRIPATHI M, GUPTA P, et al . Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapy[J ] . Indian J Med Res, 2017, 145(3): 317-326. DOI: 10.4103/ijmr.IJMR_710_15.

IHMSEN H, SAARI T I. Dexmedetomidine. pharmacokinetics and pharmacodynamics[J]. Anaesthesist, 2012, 61(12): 1059-1066. DOI: 10.1007/s00101-012-2114-1.

SPATZENEGGER M, JAEGER W. Clinical importance of hepatic cytochrome P450 in drug metabolism[J]. Drug Metab Rev, 1995, 27(3): 397-417. DOI: 10.3109/03602539508998329.

ZHOU X Q, ZHAO J L, TU H Y, et al . The effect of age on outpatient pediatric procedural sedation with intranasal dexmedetomidine and oral midazolam[J ] . Eur J Pediatr, 2024, 183(1): 169-177. DOI : 10.1007/s00431-023-05240-5.

TATEISHI T, NAKURA H, ASOH M, et al . A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy[J ] . Life Sci, 1997, 61(26): 2567-2574. DOI: 10.1016/s0024-3205(97)01011-4.

WANG J, LI Y, XIAO S N, et al . Efficacy and safety of intranasal dexmedetomidine versus oral chloral hydrate as sedatives for pediatric patients: a systematic review and meta-analysis[J ] . J Investig Med, 2022, 70(5): 1219-1224. DOI: 10.1136/jim-2021-002038.

中华医学会麻醉学分会. 2017版中国麻醉学指南与专家共识[M]. 北京: 人民卫生出版社, 2017: 286-287.

Anesthesiology Branch of Chinese Medical Association. Chinese anesthesiology guide and expert consensus (2017)[M]. Beijing: People's Health Publishing House, 2017: 286-287.

CHEN H, YANG F, YE M, et al . Intranasal dexmedetomidine is an effective sedative agent for electroencephalography in children[J ] . BMC Anesthesiol, 2020, 20(1): 61. DOI: 10.1186/s12871-020-00978-z.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

急性前循环大血管闭塞性卒中患者血管内治疗后发生卒中相关性肺炎的危险因素分析

核仁磷酸蛋白1突变的分子异质性对急性髓系白血病预后的影响

非肌层浸润性膀胱癌二次电切术后疗效评估及预后影响因素分析

Stanford A型主动脉夹层术后急性肾功能损伤的发生情况及其危险因素分析

胚胎着床位置对前置胎盘的预测价值及相关影响因素分析